New search Hide text from Guidelines
C CARDIOVASCULAR SYSTEMC10 LIPID MODIFYING AGENTS
| The DDDs are based on the treatment of hypercholesterolemia. |
C10B LIPID MODIFYING AGENTS, COMBINATIONS
Fixed combinations of blood glucose-lowering drugs and lipid modifying agents are classified in A10B.
| For fixed combinations in C10B the DDD is based on dosing frequency only. This implies that 1 UD (1 tablet) is the DDD for all products given once daily and the DDD for products given twice daily and three times daily is 2 UD (2 tablets) and 3 UD (3 tablets) respectively. |
C10BA HMG CoA reductase inhibitors in combination with other lipid modifying agents
| ATC code | Name | DDD | U | Adm.R | Note |
| C10BA01 | lovastatin and nicotinic acid |
Last updated: 2019-12-16